(Q40630400)

22 September 2017

Small molecule inhibition of hepatitis C virus E2 binding to CD81 (English)

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00406-9

15 March 2024

1 reference

Muthu Dhanasekaran

4

1 reference

22 September 2017

Scott E. VanCompernolle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517089

15 March 2024

Alexander V. Wiznycia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517089

15 March 2024

Jeremy R. Rush

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517089

15 March 2024

Paul W. Baures

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517089

15 March 2024

Scott C. Todd

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517089

15 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

22 September 2017

15 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14517089

full work available at URL

15 March 2024

https://api.elsevier.com/content/article/PII:S0042682203004069?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00406-9

https://api.elsevier.com/content/article/PII:S0042682203004069?httpAccept=text/plain

15 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00406-9

15 March 2024

1 reference

22 September 2017

314

1 reference

22 September 2017

371-380

1 reference

22 September 2017

1

1 reference

Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Heterocyclic HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

1 reference

7 January 2021

Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

PGRL is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

New developments in anti-HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Structural characterization of peptide fragments from hCD81-LEL.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Immunopathogenesis of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

The gamete fusion process is defective in eggs of Cd9-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Crystallization and preliminary crystallographic studies on the large extracellular domain of human CD81, a tetraspanin receptor for hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Severely reduced female fertility in CD9-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Hepatitis C: an epidemiological review

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Requirement of CD9 on the egg plasma membrane for fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Structure-function analysis of hepatitis C virus envelope-CD81 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Recent advances in the molecular biology of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

CD81 and CD28 costimulate T cells through distinct pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

An improved method for the synthesis of dissymmetric N,N'-disubstituted imidazole-4,5-dicarboxamides

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

The ins and outs of the transmembrane 4 superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

Synthesis and antibacterial activity of 6- and 7- (2-(5-carboxyimidazole-4-carboxamido)phenylacetamido)-penicillins and cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900406-9

7 January 2021

[Participation of adenosine receptors in regulating the functional activity of neuronal chromatin by antifeines]

36

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00406-9

15 March 2024

Identifiers

1 reference

22 September 2017

1 reference